15 research outputs found
Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
Background: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks. Methodology/Principal Findings: Included were 3763 treatment-change episodes (TCEs) for which a HIV-1 genotype was available at the time of changing treatment with at least one follow-up viral load measurement. Genotypic susceptibility scores for the active regimens were calculated using scores defined by each interpretation system. Using logistic regression, we determined the association between the genotypic susceptibility score and proportion of TCEs having an undetectable viral load (<50 copies/ml) at 12 (8-16) weeks (2152 TCEs), 24 (16-32) weeks (2570 TCEs), and 48 (44-52) weeks (1083 TCEs). The Area under the ROC curve was calculated using a 10-fold cross-validation to compare the different interpretation systems regarding the sensitivity and specificity for predicting undetectable viral load. The mean genotypic susceptibility score of the systems was slightly smaller for HIVdb, with 1.92±1.17, compared to Rega and ANRS, with 2.22±1.09 and 2.23±1.05, respectively. However, similar odds ratio's were found for the association between each-unit increase in genotypic susceptibility score and undetectable viral load at week 12; 1.6 [95% confidence interval 1.5-1.7] for HIVdb, 1.7 [1.5-1.8] for ANRS, and 1.7 [1.9-1.6] for Rega. Odds ratio's increased over time, but remained comparable (odds ratio's ranging between 1.9-2.1 at 24 weeks and 1.9-2.
RegaDB: Community-driven data management and analysis for infectious diseases
Summary: RegaDB is a free and open source data management and analysis environment for infectious diseases. RegaDB allows clinicians to store, manage and analyse patient data, including viral genetic sequences. Moreover, RegaDB pr
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
The viral load response and GSS groups at different time points.
<p>The percentages of treatment-change episodes with an undetectable viral load (<50 copies/ml) are shown for each GSS group at week 12, week 24, and week 48 for ANRS, HIVdb and Rega.</p
Multiple cross-validation for calculating AUC for the different interpretation systems.
<p>*AUCs (area under the receiver operating characteristic curve) were obtained from 10-fold cross-validated predictions. AUCs of 0.5 indicate that the interpretation system is not an explanatory factor for the percentage undetectable viral load.</p
Total Genotypic Susceptibility Scores for ANRS, HIVdb, and Rega.
<p>Total Genotypic Susceptibility Scores were calculated using the arithmetic sum of the individual scores given by the systems for each specific drug given in a regimen. We classified the GSS score for ANRS, HIVdb, and Rega in the following categories: 0 to <1, 1 to <2, 2 to <3, 3 to <4, and ≥4. GSS scores were calculated for 3759 TCEs.</p
Association of undetectable viral load and Genotypic Susceptibility Score over time.
<p>Kaplan Meier curves showing the association between time to undetectable viral load and the proportion of TCEs having an undetectable viral load for the 5 Genotypic Susceptibility Score groups for (A) ANRS (B) HIVdb and (C) Rega. Due to lost to follow-up at later viral load measurement time points, we limited the follow-up time to 30 weeks.</p
ROC curves for the logistic models for ANRS, HIVdb, and Rega at 12 weeks.
<p>The sensitivity, 1-specificity, and specificity are given in the table for the cut-off points 0.5 (A), 1.5 (B), 2.5 (C), and 3.5 (D) for ANRS, HIVdb, and Rega.</p
Association between Genotypic Susceptibility Score and undetectable viral load.
<p>The adjusted odds ratios (ORs) with 95% confidence intervals for RNA levels <50 copies/ml at (A) 12 weeks, (B) 24 weeks, and (C) 48 weeks per unit increase of GSS according to ANRS, HIVdb, and Rega. These odds ratios were adjusted for log viral load at start of therapy and real time to viral load measurement, and similar to the unadjusted odds ratios.</p